Eleanor Baker - Feb 28, 2022 Form 4 Insider Report for HESKA CORP (HSKA)

Role
EVP, Managing Dir. & COO, scil
Signature
/s/ Catherine Grassman For: Eleanor Baker
Stock symbol
HSKA
Transactions as of
Feb 28, 2022
Transactions value $
-$3,513,840
Form type
4
Date filed
6/14/2023, 06:27 PM
Previous filing
Sep 28, 2021
Next filing
Mar 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HSKA Common Stock Award $0 +16.8K +197.86% $0.00 25.2K Jun 13, 2023 Direct F1, F2
transaction HSKA Common Stock Award $0 +4.06K +16.08% $0.00 29.3K Jun 13, 2023 Direct F3
transaction HSKA Common Stock Disposed to Issuer -$3.51M -29.3K -100% $120.00 0 Jun 13, 2023 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HSKA Performance Shares Disposed to Issuer -750 -100% 0 Jun 13, 2023 Common Stock 750 Direct F5, F6
transaction HSKA Non-Qualified Stock Option (right to buy) Award $0 +12.5K $0.00 12.5K Feb 28, 2022 Common Stock 12.5K $60.94 Direct F7
transaction HSKA Non-Qualified Stock Option (right to buy) Award $0 +22.5K +180% $0.00 35K Jun 13, 2023 Common Stock 22.5K $60.94 Direct F8
transaction HSKA Non-Qualified Stock Option (right to buy) Disposed to Issuer -35K -100% 0 Jun 13, 2023 Common Stock 35K $60.94 Direct F7, F8, F9
transaction HSKA Incentive Stock Option (right to buy) Disposed to Issuer -1 -100% 0 Jun 13, 2023 Common Stock 1 $60.94 Direct F9, F10
transaction HSKA Non-Qualified Stock Option (right to buy) Disposed to Issuer -10K -100% 0 Jun 13, 2023 Common Stock 10K $60.94 Direct F9, F10
transaction HSKA Incentive Stock Option (right to buy) Disposed to Issuer -1.5K -100% 0 Jun 13, 2023 Common Stock 1.5K $98.95 Direct F9, F11
transaction HSKA Incentive Stock Option (right to buy) Disposed to Issuer -2.71K -100% 0 Jun 13, 2023 Common Stock 2.71K $71.84 Direct F9, F12
transaction HSKA Non-Qualified Stock Option (right to buy) Disposed to Issuer -9.29K -100% 0 Jun 13, 2023 Common Stock 9.29K $71.84 Direct F9, F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Eleanor Baker is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of March 31, 2023, by and among the Issuer, Antech Diagnostics, Inc., a California corporation ("Acquiror"), Helsinki Merger Sub LLC, a Delaware limited liability company and a wholly-owned subsidiary of Acquiror, and, solely for purposes of Section 9.15 of the Merger Agreement, Mars, Incorporated, a Delaware corporation, these shares of performance-based restricted stock of the Issuer were fully accelerated assuming maximum level of performance immediately prior to the effectiveness of the merger.
F2 Includes 305 shares of common stock of the Issuer purchased under the Issuer's employee stock purchase plan on May 26, 2023.
F3 Pursuant to the Merger Agreement, these performance-based restricted stock units were fully accelerated assuming target level of performance immediately prior to the effectiveness of the merger.
F4 Disposed of pursuant to the Merger Agreement in exchange for cash consideration of $120.00 per share of common stock of the Issuer (the "Merger Consideration") on the effective date of the merger.
F5 Pursuant to the Merger Agreement, these performance shares of the Issuer were fully accelerated assuming maximum level of performance immediately prior to the effectiveness of the merger and canceled in the merger in exchange for an amount in cash equal to $120.00 per share.
F6 1,500 performance shares previously vested and settled.
F7 Stock options of the Issuer became vested and exercisable upon achieving performance vesting conditions on February 28, 2022.
F8 Pursuant to the Merger Agreement, these stock options of the Issuer were fully accelerated assuming maximum level of performance immediately prior to the effectiveness of the merger.
F9 Stock options of the Issuer were canceled in the merger in exchange for an amount in cash equal to the difference, if any, between the Merger Consideration and the exercise price of such stock options.
F10 These stock options of the Issuer vested in two equal installments on December 31, 2021 and on December 31, 2022.
F11 These stock options of the Issuer vested monthly in equal installments over four years through October 24, 2022.
F12 These stock options of the Issuer vested in three equal installments on September 24, 2020, September 24, 2021 and September 24, 2022.